D-Penicillamine Dosing for Wilson Disease in Children
For children with Wilson disease, D-penicillamine should be dosed at 20 mg/kg/day, rounded to the nearest 250 mg, divided into 2-3 doses taken on an empty stomach, with pyridoxine supplementation of 25 mg/day. 1
Dosing Algorithm
Initial Dosing Strategy
The evidence strongly supports a gradual dose escalation approach to minimize adverse effects, particularly neurological deterioration:
- Start low: Begin with 125-250 mg/day
- Titrate slowly: Increase by 250 mg increments every 4-7 days
- Target dose: 20 mg/kg/day (rounded to nearest 250 mg) 1
- Maximum: 1000-1500 mg/day in children, divided into 2-4 doses 1
This gradual escalation is critical because administration of doses ≥1500 mg per day at once may lead to rapid and often irreversible neurological deterioration 1.
Administration Requirements
- Timing: Give 1 hour before meals or 2 hours after meals 2
- Separation: At least 1 hour apart from any other drug, food, or milk 2
- Pyridoxine: Mandatory 25 mg/day supplementation (D-penicillamine increases pyridoxine requirements) 1, 2
Monitoring and Dose Adjustment
Initial Phase (First 3 Months)
Target a 24-hour urinary copper excretion >2 mg (>32 μmol) during the first week of therapy. Continue the dose that achieves this for approximately 3 months 2.
Maintenance Phase
After 3 months, the most reliable monitoring parameter is free (non-ceruloplasmin-bound) copper in serum:
- Target: <10 mcg/dL (<100 μg/L) 1
- Adequately treated patients typically maintain levels in this range
Critical Safety Considerations
Neurological Disease Warning
In patients with neurological Wilson disease, D-penicillamine carries a 13.8% risk of neurological worsening 1. The gradual dose escalation strategy is particularly important in these patients. Consider alternative agents (trientine or zinc) as first-line therapy for neurological presentations.
Common Pitfalls to Avoid
- Rapid dose escalation: Never start at full dose—this significantly increases risk of irreversible neurological deterioration
- Rapid reintroduction: After treatment interruption, do not restart at full dose; use gradual escalation 1
- Missing pyridoxine: Always supplement—deficiency is inevitable without it 1, 2
- Taking with food: Food significantly impairs absorption 2
Adverse Event Monitoring
Severe side effects requiring discontinuation occur in approximately 30% of patients 1. Monitor for:
- Early reactions (1-3 weeks): Fever, rash, lymphadenopathy, cytopenias, proteinuria 1
- Hematological toxicity: Check CBC regularly; discontinue immediately for severe thrombocytopenia or aplasia 1
- Renal toxicity: Monitor urinalysis; proteinuria >1 g/24h requires dose reduction or discontinuation 2
- Late reactions: Lupus-like syndrome, dermatological changes, myasthenia 1
Alternative Dosing Strategy
Recent research suggests a combination approach may be safer and equally effective:
Low-dose D-penicillamine (8-10 mg/kg/day) + high-dose zinc sulfate has shown favorable outcomes in 89.2% of pediatric patients with no penicillamine-induced neurological deterioration and side effects in <11% 3. This represents a significant safety improvement over standard dosing, though it deviates from established guidelines.
Surgical Considerations
If surgery is planned, reduce dose to 250 mg/day for 6 weeks preoperatively and continue until wound healing is complete 2. D-penicillamine affects collagen cross-linking and can impair wound healing.